Zevenbergen Capital Investments LLC Sells 61,819 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Zevenbergen Capital Investments LLC lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 12.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 423,239 shares of the biotechnology company's stock after selling 61,819 shares during the quarter. Axon Enterprise comprises about 5.1% of Zevenbergen Capital Investments LLC's portfolio, making the stock its 5th largest position. Zevenbergen Capital Investments LLC owned 0.56% of Axon Enterprise worth $251,539,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in AXON. PNC Financial Services Group Inc. raised its position in Axon Enterprise by 17.5% in the 3rd quarter. PNC Financial Services Group Inc. now owns 5,627 shares of the biotechnology company's stock worth $2,249,000 after purchasing an additional 840 shares during the period. Jennison Associates LLC grew its stake in shares of Axon Enterprise by 48.2% during the third quarter. Jennison Associates LLC now owns 3,977 shares of the biotechnology company's stock valued at $1,589,000 after buying an additional 1,294 shares during the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in shares of Axon Enterprise in the third quarter worth approximately $120,553,000. Great Valley Advisor Group Inc. raised its holdings in shares of Axon Enterprise by 306.1% in the third quarter. Great Valley Advisor Group Inc. now owns 3,850 shares of the biotechnology company's stock worth $1,539,000 after buying an additional 2,902 shares during the period. Finally, Penserra Capital Management LLC lifted its stake in shares of Axon Enterprise by 12.6% during the 3rd quarter. Penserra Capital Management LLC now owns 6,297 shares of the biotechnology company's stock worth $2,516,000 after acquiring an additional 706 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Remove Ads

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the transaction, the director now directly owns 1,627 shares of the company's stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the sale, the director now owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders own 6.10% of the company's stock.

Axon Enterprise Stock Up 0.8 %

Axon Enterprise stock traded up $4.66 during trading hours on Tuesday, reaching $577.18. The stock had a trading volume of 439,520 shares, compared to its average volume of 835,219. The company has a market cap of $44.23 billion, a price-to-earnings ratio of 149.14, a PEG ratio of 5.17 and a beta of 1.12. The business's 50 day moving average price is $591.92 and its 200-day moving average price is $546.67. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $715.99. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. Northcoast Research lowered Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. Barclays reaffirmed a "hold" rating on shares of Axon Enterprise in a research note on Monday, March 10th. TD Cowen started coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a "buy" rating and a $700.00 price objective for the company. Robert W. Baird upped their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a research note on Friday, December 6th. Finally, Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of "Moderate Buy" and an average target price of $604.67.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.